Blood Pressure Management

No patient weight set. Open Pediatric Weight, Age, Height, or Length Tape to enable dose calculations.
Definitions — HTN vs urgency vs emergency
Stage 1 hypertension: SBP 130–139 OR DBP 80–89. Stage 2 hypertension: SBP ≥ 140 OR DBP ≥ 90. Hypertensive urgency: SBP > 180 and/or DBP > 120 WITHOUT acute end-organ damage. • No labs/imaging required beyond screening; treat with ORAL agents over 24–48 h. Do NOT acutely lower BP in the ED — risk of hypoperfusion (stroke, MI, AKI). • Reinstitute or up-titrate home meds; arrange close follow-up. Hypertensive emergency: SBP > 180 and/or DBP > 120 WITH acute end-organ damage. Brain: encephalopathy, ischemic stroke, ICH, SAH, PRES. Heart: ACS, acute pulmonary edema (SCAPE), aortic dissection. Kidney: AKI, microangiopathic hemolysis. Pregnancy: severe preeclampsia / eclampsia. • Treat with IV titratable agents — admit to monitored bed / ICU. General targets: ↓ MAP 10–20% in first hour, then 5–15% over next 23 h. Avoid > 25% drop in 1st hour. Scenario-specific targets override (see tables below).
First-line IV agents — adult emergency dosing
DrugDoseNotes / cautions
10–20 mg IV q10 min, double up to 80 mg (max 300 mg). Gtt 0.5–2 mg/minα + β-blocker. AVOID if HR < 60, severe asthma, decompensated HF, 2°/3° AVB
Start 5 mg/hr IV, ↑ 2.5 mg/hr q5–15 min, max 15 mg/hrDHP CCB; smooth titration. Preferred in stroke, ICH, eclampsia. Reflex tachy possible
Start 1–2 mg/hr, double q90 sec, max 16–32 mg/hrUltra-short-acting CCB. Caution: lipid emulsion (egg/soy allergy, hypertriglyceridemia)
Load 500 mcg/kg over 1 min → gtt 50–300 mcg/kg/minCardioselective β1; ideal for aortic dissection (with vasodilator), perioperative HTN
Nitroglycerin5–200 mcg/min IV (start 5–10, ↑ q3–5 min)Preload reducer. First-line in APE/SCAPE, ACS. Avoid SBP < 100, RV infarct, PDE-5 use
Nitroprusside0.25–10 mcg/kg/min IV (start low)Mixed art/venous. Cyanide / thiocyanate toxicity risk > 24 h or in renal failure. Light-protect
10–20 mg IV q20–30 min PRNUnpredictable; reflex tachy. Useful in eclampsia / pregnancy
0.625–1.25 mg IV q6hACE-i; avoid in pregnancy, bilateral RAS, AKI
5–15 mg IV q5–15 minα-blocker. First-line for catecholamine excess (pheo, , crisis, clonidine withdrawal)
High BP + LOW HR (relative bradycardia)
Avoid β-blockers (, ) and non-DHP CCBs (, ) — they will worsen bradycardia / AV block. Preferred agents: IV — DHP CCB, no AV nodal effect; smooth titration. IV — ultra-short DHP CCB, similar profile to . IV — direct arterial vasodilator; can actually raise HR (reflex), useful when bradycardic. • Nitroglycerin / Nitroprusside — vasodilators, neutral-to-↑ HR. Watch for: Cushing reflex (HTN + bradycardia + irregular respirations) → suggests ↑ ICP — DO NOT lower BP aggressively; treat ICP first (HOB 30°, mannitol/3% NaCl, neurosurgery).
Scenario · Ischemic stroke (no tPA)
First-lineAdult doseCaution / max
Permissive HTNTreat ONLY if SBP > 220 or DBP > 120; ↓ MAP ≤ 15% in 1st hrAggressive lowering worsens penumbra
IV10–20 mg q10 min, double to 80 mg (max 300 mg)Avoid HR < 60, asthma, AVB
IV gtt5 mg/hr → ↑ 2.5 mg/hr q5–15 min, max 15 mg/hrPreferred if HR-limited
AVOIDNitroprusside, sublingual nifedipine↑ ICP, uncontrolled drop
Scenario · Ischemic stroke (tPA candidate)
First-lineAdult doseCaution / max
TargetBP < 185/110 PRE-, < 180/105 × 24 h postHold if cannot achieve
IV10–20 mg q10 min × 2, then gtt 2–8 mg/minMax bolus total 300 mg
IV gtt5 mg/hr → titrate q5 min to targetMax 15 mg/hr
AVOIDSublingual nifedipine, Unpredictable / overshoots
Scenario · Aortic dissection
First-lineAdult doseCaution / max
FIRSTLoad 500 mcg/kg over 1 min → gtt 50–300 mcg/kg/minTarget HR < 60 BEFORE vasodilator
Then gtt5 mg/hr → titrate to SBP 100–120, max 15 mg/hrAdd only after HR controlled
Or Nitroprusside0.25–10 mcg/kg/min IVCyanide risk > 24 h / renal failure
Pain control 25–100 mcg IV q5–10 minReduces sympathetic drive
AVOIDVasodilator before β-blockReflex tachy → ↑ shear stress → propagation
Scenario · Acute pulmonary edema / SCAPE
First-lineAdult doseCaution / max
Nitroglycerin IVStart 50–100 mcg/min, double q3–5 min; high-dose 200–400 mcg/min OKAvoid SBP < 100, RV infarct, PDE-5 use
BiPAPIPAP 10–15 / EPAP 5–8First-line ventilation
Furosemide IV40–80 mg (or 2× home dose)Adjunct; not first-line in SCAPE
gtt1–2 mg/hr → max 16–32 mg/hrAlternative if insufficient
AVOIDβ-blockers (, )Negative inotrope in acute HF
Scenario · Acute coronary syndrome
First-lineAdult doseCaution / max
Nitroglycerin IV5–200 mcg/min IVAvoid SBP < 100, RV infarct, PDE-5
gttLoad 500 mcg/kg → 50–300 mcg/kg/minIf no contraindication
Metoprolol IV5 mg IV q5 min × 3Avoid in HF, HR < 60, hypotension
AVOIDReflex tachy → ↑ myocardial demand
Scenario · Sympathetic crisis (cocaine, MAOI, clonidine w/d)
First-lineAdult doseCaution / max
2 mg IV q5–10 min OR 5–10 mg IVFirst-line — treat agitation + HTN
IV5 mg IV q5–15 min PRNα-blocker; max 15 mg/dose
gtt5 mg/hr, max 15 mg/hr2nd-line vasodilator
AVOIDβ-blocker monotherapy (incl. controversial)Unopposed α → worse HTN, coronary spasm
Scenario · Eclampsia / severe preeclampsia
First-lineAdult doseCaution / max
4–6 g IV load over 20 min → 1–2 g/hr gttWatch DTRs / RR; at bedside
IV20 mg → 40 mg → 80 mg q10 min (max 300 mg)First-line BP agent in pregnancy
IV5–10 mg q20 min PRNAlternative; reflex tachy
gtt5 mg/hr → max 15 mg/hrIf refractory
AVOIDACE-i, ARB, Fetal toxicity / cyanide
Scenario · Pheochromocytoma
First-lineAdult doseCaution / max
IV5 mg IV q5–15 min PRNα-blockade FIRST
gtt5 mg/hr → max 15 mg/hrAdjunct vasodilator
β-blocker (after α) 50–300 mcg/kg/min OR metoprolol 5 mg IVONLY after adequate α-block
AVOIDβ-blocker monotherapyUnopposed α → hypertensive crisis
Brain bleed — overview & shared principles
Goal: control BP without dropping cerebral perfusion or raising ICP. • Use IV titratable agents with NO direct ICP effect (DHP CCBs). • Establish arterial line within 30 min for beat-to-beat BP. • HOB 30°, midline neck, normothermia, normoglycemia, normocapnia (PaCO₂ 35–40). • If Cushing reflex (HTN + bradycardia + irregular resp) → treat ICP FIRST (3% NaCl 250 mL or mannitol 1 g/kg, hyperventilate to PaCO₂ 30–35 as bridge, neurosurgery STAT). DO NOT aggressively lower BP — preserves CPP. • CPP target ≥ 60–70 mmHg (CPP = MAP − ICP).
ICH (intracerebral hemorrhage) — exact dosing
StepDrug & titrationTarget / max
TargetSBP 140 (range 140–160) per AHA / INTERACT-2 / ATACH-2Achieve within 1 h; maintain × 24 h
1st-line IV gtt — start 5 mg/hr → ↑ 2.5 mg/hr q5–15 minMax 15 mg/hr; wean once at goal
1st-line alt IV gtt — start 1–2 mg/hr, double q90 secMax 16–32 mg/hr; lipid load limits
2nd-line bolus 10–20 mg IV q10 min (double to 80 mg)Max cumulative 300 mg; HOLD if HR < 60
2nd-line gtt load 500 mcg/kg → 50–300 mcg/kg/minUse if HR-driven or β-block needed
ReversalIf on warfarin: 25–50 U/kg + Vit K 10 mg IV. DOAC: (Xa) or (dabigatran)Within 60 min of presentation
AVOIDNitroprusside (↑ ICP, cerebral steal, cyanide)
AVOID (unpredictable, prolonged, reflex tachy)
AVOIDSublingual nifedipine (uncontrolled drop)
SAH (subarachnoid hemorrhage) — exact dosing
StepDrug & titrationTarget / max
Target (unsecured aneurysm)SBP < 160 (some centers < 140)Until aneurysm secured (coil/clip)
Target (secured)Permissive HTN — induced HTN if vasospasm (SBP up to 180–220)Maintain euvolemia
1st-line IV gtt — start 5 mg/hr → ↑ 2.5 mg/hr q5–15 minMax 15 mg/hr
1st-line alt IV gtt — 1–2 mg/hr, double q90 secMax 16–32 mg/hr
Vasospasm prophylaxisNimodipine 60 mg PO/NG q4h × 21 d (start within 96 h)↓ to 30 mg q2h if hypotension
Pain / sedation 25–50 mcg IV q1h + acetaminophen 1 g IV q6hLower sympathetic drive
2nd-line 10–20 mg IV q10 min (max 300 mg)Avoid
AVOIDNitroprusside (↑ ICP, steal, cyanide)
AVOID (unpredictable, masks neuro exam)
AVOIDAggressive overshoot — ↓ CPP risks delayed cerebral ischemia
Brain bleed · titration & monitoring rules
• Arterial line within 30 min — cuff BP under-reads in low CO. • Reassess BP + neuro exam q5 min during titration, q15 min once at goal. • Pause titration if MAP drops > 20% from baseline OR new neuro deficit — bolus 250 mL NS, recheck CT. • Treat pain (), nausea (), bladder distension, hypoxia — all elevate BP. • Reverse anticoagulation in parallel (do not wait for BP control). • Glucose 140–180; temp < 37.5; Na 140–145 (avoid hyponatremia → cerebral edema).
Oral agents — hypertensive urgency (no end-organ damage)
DrugDoseNotes
PO200–400 mg PO, may repeat q2–3 hOnset 1–2 h; same cautions as IV
Captopril SL/PO12.5–25 mg PO, repeat q1–2 hOnset 15–30 min; avoid pregnancy / AKI / bilat RAS
Clonidine PO0.1–0.2 mg PO, then 0.1 mg q1h (max 0.7 mg)Sedation; rebound HTN if stopped
Amlodipine PO5–10 mg PO dailySlow onset; for outpatient titration
PO10–25 mg PO q6–8 hReflex tachy; avoid as monotherapy